Venus Remedies, 526953, VENUSREM Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

338.05
4.45
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

360.39
N/A
0.76

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.95
6.50
19.41

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-6.28
1.17
10.58

PAT CAGR (%)

10 Years
5 Years
3 Years

2.75
-
-

P:E (Median)

8 Years
5 Years
3 Years

8.40
4.79
4.51

P:BV (Average)

8 Years
5 Years
3 Years

0.43
0.46
0.63

EV:EBITDA (Average)

8 Years
5 Years
3 Years

6.66
7.73
8.27

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var% Mar 21 Mar 20 Var%
Net Sales 117.44 114.07 2.95% 192.64 118.41 62.69% 136.85 179.71 -23.85% 102.44 79.22 29.31%
Expenses 103.21 101.03 2.16% 164.71 113.25 45.44% 117.49 158.91 -26.07% 94.57 72.82 29.87%
EBITDA 14.23 13.04 9.13% 27.93 5.16 441.28% 19.36 20.80 -6.92% 7.87 6.41 22.78%
EBIDTM 12.11% 11.43% 14.50% 4.36% 14.15% 11.57% 7.68% 8.09%
Other Income 1.07 1.15 -6.96% 2.96 11.74 -74.79% 1.92 1.51 27.15% 3.36 2.70 24.44%
Interest 0.00 1.73 -100.00% 0.00 7.33 -100.00% 0.00 2.79 -100.00% 0.87 0.00 0
Depreciation 8.40 8.42 -0.24% 8.46 8.35 1.32% 8.37 8.33 0.48% 9.18 6.22 47.59%
PBT 6.90 8.50 -18.82% 22.44 8.82 154.42% 12.91 2.01 542.29% 21.74 -5.93 -
Tax -0.95 2.21 - -1.69 1.49 - -1.68 0.00 - -16.91 0.82 -
PAT 7.85 6.29 24.80% 24.13 7.33 229.20% 14.59 2.01 625.87% 38.65 -6.74 -
PATM 6.68% 5.52% 12.52% 6.19% 10.66% 1.12% 37.73% -8.51%
EPS 5.86 4.70 24.68% 18.01 5.47 229.25% 10.89 1.50 626.00% 28.84 -5.03 -

Description Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var% Mar 21 Mar 20 Var%
Net Sales 124.34 121.94 1.97% 202.56 126.07 60.67% 129.81 188.75 -31.23% 111.37 83.06 34.08%
Expenses 111.91 103.86 7.75% 175.26 115.42 51.85% 112.98 168.19 -32.83% 106.88 75.53 41.51%
EBITDA 12.44 18.08 -31.19% 27.30 10.65 156.34% 16.83 20.55 -18.10% 4.50 7.53 -40.24%
EBIDTM 10.00% 14.83% 13.48% 8.45% 12.96% 10.89% 4.04% 9.07%
Other Income 1.22 1.83 -33.33% 2.89 12.28 -76.47% 1.95 2.04 -4.41% 3.49 1.37 154.74%
Interest 0.31 1.81 -82.87% 0.03 7.39 -99.59% 0.14 2.85 -95.09% 0.96 -1.82 -
Depreciation 8.64 8.70 -0.69% 8.71 8.61 1.16% 8.62 8.59 0.35% 9.38 6.47 44.98%
PBT 4.70 13.86 -66.09% 21.46 14.52 47.80% 10.02 1.97 408.63% 18.20 -4.56 -
Tax -0.95 2.21 - -1.69 1.49 - -1.68 0.00 - -16.91 0.82 -
PAT 5.65 11.65 -51.50% 23.15 13.03 77.67% 11.70 1.97 493.91% 35.11 -5.38 -
PATM 4.54% 9.56% 11.43% 10.33% 9.01% 1.05% 31.53% -6.48%
EPS 4.22 9.44 -55.30% 17.32 10.55 64.17% 8.75 1.60 446.88% 28.45 -4.36 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 549.37 514.62 320.23 301.84 355.07 375.45 402.69 451.88 526.06 461.34 405.19 Net Sales Growth 11.79% 60.70% 6.09% -14.99% -5.43% -6.76% -10.89% -14.10% 14.03% 13.86% Cost Of Goods Sold 356.91 336.68 176.81 181.78 205.42 186.69 194.64 213.05 298.96 263.27 226.04 Gross Profit 192.46 177.94 143.42 120.06 149.65 188.76 208.05 238.82 227.10 198.07 179.15 GP Margin 35.03% 34.58% 44.79% 39.78% 42.15% 50.28% 51.67% 52.85% 43.17% 42.93% 44.21% Total Expenditure 479.98 467.76 277.16 267.55 311.51 328.16 323.14 364.94 392.83 342.85 299.29 Power & Fuel Cost - 3.39 3.41 3.50 3.02 3.08 2.90 3.28 3.11 2.86 2.49 % Of Sales - 0.66% 1.06% 1.16% 0.85% 0.82% 0.72% 0.73% 0.59% 0.62% 0.61% Employee Cost - 35.89 33.79 30.26 27.82 25.02 25.02 27.26 25.57 23.24 20.58 % Of Sales - 6.97% 10.55% 10.03% 7.84% 6.66% 6.21% 6.03% 4.86% 5.04% 5.08% Manufacturing Exp. - 20.63 18.35 18.98 34.28 75.01 58.94 73.60 20.75 19.72 17.45 % Of Sales - 4.01% 5.73% 6.29% 9.65% 19.98% 14.64% 16.29% 3.94% 4.27% 4.31% General & Admin Exp. - 13.76 15.22 9.79 11.86 12.20 10.85 14.36 13.81 11.10 11.34 % Of Sales - 2.67% 4.75% 3.24% 3.34% 3.25% 2.69% 3.18% 2.63% 2.41% 2.80% Selling & Distn. Exp. - 57.40 29.59 23.24 29.11 26.17 30.78 33.39 30.64 22.66 21.18 % Of Sales - 11.15% 9.24% 7.70% 8.20% 6.97% 7.64% 7.39% 5.82% 4.91% 5.23% Miscellaneous Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 21.18 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0.05% EBITDA 69.39 46.86 43.07 34.29 43.56 47.29 79.55 86.94 133.23 118.49 105.90 EBITDA Margin 12.63% 9.11% 13.45% 11.36% 12.27% 12.60% 19.75% 19.24% 25.33% 25.68% 26.14% Other Income 9.31 17.76 3.58 4.51 1.19 3.10 0.67 0.55 0.41 0.39 0.38 Interest 0.87 12.73 13.05 25.15 35.44 35.87 36.74 40.70 29.29 24.45 27.26 Depreciation 34.41 34.28 31.05 32.95 32.73 39.32 40.47 44.74 38.61 31.76 23.86 PBT 63.99 17.62 2.55 -19.30 -23.42 -24.80 3.01 2.04 65.73 62.67 55.15 Tax -21.23 -13.21 1.96 -1.15 3.16 -4.56 1.81 -2.51 4.78 5.53 5.12 Tax Rate -33.18% -32.17% -31.31% 4.07% -13.49% 18.39% 60.13% -123.04% 7.27% 8.82% 9.28% PAT 85.22 54.27 -8.23 -27.11 -26.58 -20.24 1.20 4.55 60.95 57.15 50.03 PAT before Minority Interest 85.22 54.27 -8.23 -27.11 -26.58 -20.24 1.20 4.55 60.95 57.15 50.03 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.51% 10.55% -2.57% -8.98% -7.49% -5.39% 0.30% 1.01% 11.59% 12.39% 12.35% PAT Growth 858.61% - - - - - -73.63% -92.53% 6.65% 14.23% EPS 63.60 40.50 -6.14 -20.23 -19.84 -15.10 0.90 3.40 45.49 42.65 37.34

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 568.08 548.12 339.33 321.89 372.41 400.04 418.27 463.99 541.56 468.64 409.84 Net Sales Growth 9.28% 61.53% 5.42% -13.57% -6.91% -4.36% -9.85% -14.32% 15.56% 14.35% Cost Of Goods Sold 365.28 340.79 174.31 181.95 205.08 227.07 238.51 268.94 300.00 262.26 225.91 Gross Profit 202.80 207.33 165.02 139.94 167.33 172.97 179.77 195.05 241.55 206.38 183.92 GP Margin 35.70% 37.83% 48.63% 43.47% 44.93% 43.24% 42.98% 42.04% 44.60% 44.04% 44.88% Total Expenditure 507.03 494.35 298.52 289.37 332.94 349.32 337.11 374.81 403.33 348.53 306.96 Power & Fuel Cost - 4.58 4.73 4.86 4.29 4.14 4.01 3.80 3.38 3.05 2.71 % Of Sales - 0.84% 1.39% 1.51% 1.15% 1.03% 0.96% 0.82% 0.62% 0.65% 0.66% Employee Cost - 46.02 46.02 42.10 39.31 34.27 32.44 32.36 30.45 27.30 24.83 % Of Sales - 8.40% 13.56% 13.08% 10.56% 8.57% 7.76% 6.97% 5.62% 5.83% 6.06% Manufacturing Exp. - 22.86 20.84 21.01 36.10 42.48 15.70 17.29 22.10 20.61 18.18 % Of Sales - 4.17% 6.14% 6.53% 9.69% 10.62% 3.75% 3.73% 4.08% 4.40% 4.44% General & Admin Exp. - 16.45 17.57 11.85 13.52 13.26 11.97 15.67 14.74 11.82 12.14 % Of Sales - 3.00% 5.18% 3.68% 3.63% 3.31% 2.86% 3.38% 2.72% 2.52% 2.96% Selling & Distn. Exp. - 63.64 35.05 27.60 34.65 28.10 34.48 36.75 32.65 23.50 22.98 % Of Sales - 11.61% 10.33% 8.57% 9.30% 7.02% 8.24% 7.92% 6.03% 5.01% 5.61% Miscellaneous Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 22.98 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0.05% EBITDA 61.07 53.77 40.81 32.52 39.47 50.72 81.16 89.18 138.23 120.11 102.88 EBITDA Margin 10.75% 9.81% 12.03% 10.10% 10.60% 12.68% 19.40% 19.22% 25.52% 25.63% 25.10% Other Income 9.55 19.63 5.31 6.09 2.39 4.28 2.01 0.68 0.47 0.44 0.49 Interest 1.44 13.02 13.34 25.41 35.56 36.38 37.98 41.21 29.40 24.63 27.49 Depreciation 35.35 35.28 32.01 33.98 33.83 40.26 41.68 46.00 40.22 33.08 25.02 PBT 54.38 25.11 0.78 -20.77 -27.53 -21.64 3.51 2.65 69.08 62.84 50.85 Tax -21.23 -13.21 1.96 -1.15 3.16 -4.56 1.81 -2.51 4.78 5.53 3.78 Tax Rate -39.04% -27.21% -24.41% 3.87% -11.48% 21.07% 51.57% -94.72% 6.92% 8.80% 7.43% PAT 75.61 61.77 -10.00 -28.57 -30.69 -17.08 1.70 5.16 64.30 57.31 47.08 PAT before Minority Interest 75.61 61.77 -10.00 -28.57 -30.69 -17.08 1.70 5.16 64.30 57.31 47.08 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.31% 11.27% -2.95% -8.88% -8.24% -4.27% 0.41% 1.11% 11.87% 12.23% 11.49% PAT Growth 255.48% - - - - - -67.05% -91.98% 12.20% 21.73% EPS 56.43 46.10 -7.46 -21.32 -22.90 -12.75 1.27 3.85 47.99 42.77 35.13

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 400.18 332.25 340.95 367.99 394.23 444.43 466.24 467.42 392.24 319.11 Share Capital 12.34 12.34 12.34 12.34 12.34 11.44 11.44 11.44 10.54 9.74 Total Reserves 374.09 319.91 328.61 355.65 381.89 432.99 454.79 455.97 376.92 300.35 Non-Current Liabilities 58.81 96.03 136.75 157.89 179.52 212.03 221.50 161.27 147.18 113.50 Secured Loans 0.00 23.92 60.88 86.02 112.69 134.55 150.91 114.28 103.89 75.45 Unsecured Loans 47.52 48.34 55.20 50.84 49.13 56.47 51.34 25.22 25.22 23.68 Long Term Provisions 7.38 6.63 5.32 4.50 4.29 3.79 3.78 3.31 2.91 2.50 Current Liabilities 87.82 215.98 254.46 222.61 193.71 177.59 157.06 207.33 190.06 154.13 Trade Payables 68.36 33.96 33.41 27.19 30.56 23.90 25.76 28.14 17.87 12.33 Other Current Liabilities 18.78 99.99 107.61 76.87 45.70 36.63 13.99 54.12 57.88 43.22 Short Term Borrowings 0.00 81.42 108.92 117.23 115.70 115.09 115.40 110.08 95.68 83.24 Short Term Provisions 0.68 0.61 4.52 1.32 1.76 1.97 1.91 14.99 18.63 15.33 Total Liabilities 546.81 644.26 732.16 748.49 767.46 834.05 844.80 836.02 729.48 586.74 Net Block 244.20 271.47 346.89 369.93 389.38 433.52 425.77 416.09 380.92 335.86 Gross Block 581.73 589.77 674.06 669.01 655.78 660.61 612.50 555.61 481.83 405.01 Accumulated Depreciation 337.53 318.30 327.17 299.08 266.40 227.09 186.73 139.52 100.91 69.15 Non Current Assets 335.51 360.33 478.57 499.96 517.54 575.53 618.72 567.61 500.20 413.61 Capital Work in Progress 25.11 24.63 64.76 64.76 66.25 80.37 78.30 67.80 47.81 23.00 Non Current Investment 0.14 0.14 0.14 0.14 28.74 28.74 28.74 28.74 28.74 28.74 Long Term Loans & Adv. 66.06 64.08 66.78 65.13 33.17 32.90 85.91 54.98 42.74 26.01 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 211.30 283.94 253.59 248.53 249.93 258.53 226.08 268.41 229.28 173.13 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 119.69 136.44 140.94 135.98 139.69 137.69 140.44 141.46 126.40 96.19 Sundry Debtors 16.44 29.78 31.39 44.15 41.91 53.88 59.37 62.80 53.11 44.33 Cash & Bank 27.80 1.44 1.28 3.64 3.15 3.04 3.52 4.38 6.26 2.91 Other Current Assets 47.36 55.72 5.15 4.84 65.18 63.91 22.76 59.77 43.51 29.70 Short Term Loans & Adv. 41.66 60.56 74.83 59.93 65.18 63.91 22.76 59.77 43.51 29.70 Net Current Assets 123.48 67.96 -0.87 25.93 56.22 80.94 69.02 61.08 39.21 19.00 Total Assets 546.81 644.27 732.16 748.49 767.47 834.06 844.80 836.02 729.48 586.74

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 400.28 323.37 332.52 361.91 388.67 437.62 456.68 461.61 379.13 307.29 Share Capital 12.34 12.34 12.34 12.34 12.34 11.44 11.44 11.44 10.54 9.74 Total Reserves 374.19 311.03 320.18 349.57 376.33 426.18 445.24 450.17 363.81 288.53 Non-Current Liabilities 58.12 95.82 136.68 158.47 179.52 212.05 221.55 161.75 147.18 113.51 Secured Loans 0.09 24.19 61.29 86.60 112.69 134.57 150.95 114.76 103.89 75.45 Unsecured Loans 46.74 47.87 54.73 50.84 49.13 56.47 51.34 25.22 25.22 23.68 Long Term Provisions 7.38 6.63 5.32 4.50 4.29 3.79 3.78 3.31 2.91 2.50 Current Liabilities 97.45 224.58 263.62 230.38 196.81 193.14 162.83 210.99 191.25 153.22 Trade Payables 71.36 36.70 36.00 29.33 29.73 25.14 29.56 31.22 18.76 12.55 Other Current Liabilities 21.10 101.70 110.30 78.47 46.16 42.71 15.96 54.70 58.18 43.44 Short Term Borrowings 4.30 85.58 112.80 121.26 119.16 123.32 115.40 110.08 95.68 83.24 Short Term Provisions 0.68 0.61 4.52 1.32 1.76 1.97 1.91 14.99 18.63 13.99 Total Liabilities 555.85 643.77 732.82 750.76 765.00 842.81 841.06 834.35 717.56 574.02 Net Block 261.68 289.37 364.45 389.20 406.18 452.48 443.65 439.46 401.42 355.39 Gross Block 616.32 623.96 707.02 702.77 686.50 679.57 641.12 587.38 511.00 430.25 Accumulated Depreciation 354.63 334.59 342.57 313.57 280.32 227.09 197.47 147.93 109.58 74.87 Non Current Assets 324.26 349.77 467.39 490.50 505.60 565.75 607.85 562.24 491.97 404.40 Capital Work in Progress 25.11 24.63 64.76 64.76 66.25 80.37 78.30 67.80 47.81 23.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 37.47 35.77 38.18 36.53 33.17 32.90 85.91 54.98 42.74 26.01 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 231.60 294.00 265.43 260.27 259.41 277.07 233.21 272.11 225.58 169.63 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 119.99 141.12 142.73 138.17 140.60 143.29 142.87 142.26 128.03 96.82 Sundry Debtors 32.04 30.69 38.04 47.27 47.29 61.59 63.22 64.99 47.11 40.10 Cash & Bank 28.98 2.13 2.81 3.98 3.56 7.07 3.62 4.41 6.36 2.95 Other Current Assets 50.58 55.72 5.15 4.84 67.96 65.12 23.51 60.47 44.08 29.77 Short Term Loans & Adv. 44.88 64.34 76.70 66.00 67.96 65.12 23.51 60.47 44.08 29.77 Net Current Assets 134.15 69.43 1.81 29.88 62.59 83.93 70.38 61.12 34.33 16.41 Total Assets 555.86 643.77 732.82 750.77 765.01 842.82 841.06 834.35 717.55 574.03

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 132.67 77.75 43.65 51.58 61.77 41.91 66.76 52.56 50.66 38.06 PBT 17.62 2.55 -19.30 -23.42 -24.80 3.01 2.04 65.73 62.67 55.15 Adjustment 22.64 40.39 59.20 64.73 69.30 53.72 81.90 35.95 39.38 27.76 Changes in Working Capital 68.96 20.37 3.75 10.27 17.27 -14.82 -17.18 -49.12 -51.39 -44.85 Cash after chg. in Working capital 109.23 63.31 43.65 51.58 61.77 41.91 66.76 52.56 50.66 38.06 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 23.44 14.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 55.65 -4.64 -11.27 -11.48 -18.06 3.20 -67.15 -93.75 -102.47 -93.63 Net Fixed Assets 7.56 124.42 -5.05 -11.74 18.95 -50.18 -67.39 -93.77 -101.63 -93.38 Net Investments 0.00 0.00 0.00 28.60 0.00 0.00 0.00 0.00 0.00 -0.37 Others 48.09 -129.06 -6.22 -28.34 -37.01 53.38 0.24 0.02 -0.84 0.12 Cash from Financing Activity -161.88 -72.35 -34.74 -39.61 -43.60 -45.59 -0.47 39.31 55.15 55.57 Net Cash Inflow / Outflow 26.45 0.76 -2.36 0.49 0.11 -0.48 -0.86 -1.88 3.35 0.00 Opening Cash & Equivalents 1.26 0.50 3.64 3.15 3.04 3.52 4.38 6.26 2.91 2.91 Closing Cash & Equivalent 27.70 1.26 1.28 3.64 3.15 3.04 3.52 4.38 6.26 2.91

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 132.61 77.60 45.33 31.19 58.93 46.88 67.80 52.65 52.15 41.67 PBT 25.11 0.78 -20.77 -27.53 -21.64 3.51 2.65 69.08 62.84 50.85 Adjustment 23.39 41.56 60.72 66.24 70.61 56.41 83.56 37.21 40.72 29.96 Changes in Working Capital 60.67 20.82 5.37 -7.52 9.96 -13.04 -18.40 -53.65 -51.41 -39.14 Cash after chg. in Working capital 109.17 63.16 45.33 31.19 58.93 46.88 67.80 52.65 52.15 41.67 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 23.44 14.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 55.72 -4.75 -11.33 -11.48 -18.32 2.92 -67.18 -94.66 -103.89 -95.15 Net Fixed Assets 7.56 124.42 -5.05 -11.74 18.95 -50.18 -67.39 -93.77 -101.63 -93.38 Net Investments 0.00 0.00 0.00 28.60 0.00 0.00 0.00 0.00 0.00 -0.37 Others 48.16 -129.17 -6.28 -28.34 -37.27 53.10 0.21 -0.89 -2.26 -1.40 Cash from Financing Activity -162.24 -73.00 -35.17 -39.23 -44.13 -46.35 -1.42 40.06 55.15 53.31 Net Cash Inflow / Outflow 26.09 -0.15 -1.17 -19.52 -3.51 3.46 -0.79 -1.95 3.41 -0.17 Opening Cash & Equivalents 1.94 2.03 3.98 0.00 7.07 3.62 4.41 6.36 2.95 3.12 Closing Cash & Equivalent 28.88 1.94 2.81 -19.52 3.56 7.07 3.62 4.41 6.36 2.95

Financial Ratios

Consolidated /

Standalone

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 313.10 269.21 276.25 298.16 319.42 388.42 407.48 408.51 367.54 318.30 ROA 9.11% -1.20% -3.66% -3.51% -2.53% 0.14% 0.54% 7.79% 8.68% 9.46% ROE 15.10% -2.44% -7.65% -6.98% -4.83% 0.26% 0.97% 14.26% 16.38% 18.11% ROCE 10.80% 1.15% -0.48% 1.75% 1.50% 5.11% 5.55% 13.40% 14.49% 16.94% Fixed Asset Turnover 0.88 0.51 0.45 0.54 0.57 0.63 0.77 1.02 1.04 1.12 Receivable days 16.39 34.86 45.68 44.23 46.56 51.33 49.34 40.15 38.45 36.30 Inventory Days 90.83 158.08 167.43 141.69 134.83 126.05 113.85 92.77 87.83 77.16 Payable days 55.46 42.49 37.63 31.43 27.90 25.33 24.89 20.07 14.84 10.66 Cash Conversion Cycle 51.76 150.45 175.48 154.49 153.50 152.04 138.30 112.85 111.44 102.80 Total Debt/Equity 0.12 0.65 0.86 0.82 0.78 0.74 0.68 0.62 0.70 0.71 Interest Cover 4.23 0.52 -0.12 0.34 0.31 1.08 1.05 3.24 3.56 3.02

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 313.18 262.01 269.42 293.23 314.92 382.47 399.13 403.43 355.10 306.18 ROA 10.30% -1.45% -3.85% -4.05% -2.12% 0.20% 0.62% 8.29% 8.87% 9.10% ROE 17.40% -3.05% -8.23% -8.18% -4.13% 0.38% 1.12% 15.38% 17.04% 17.73% ROCE 12.37% 0.90% -0.67% 1.17% 2.00% 5.35% 5.74% 14.06% 14.85% 16.47% Fixed Asset Turnover 0.88 0.51 0.46 0.54 0.59 0.63 0.76 0.99 1.00 1.06 Receivable days 20.89 36.97 48.37 46.34 49.67 54.45 50.42 37.72 33.88 33.71 Inventory Days 86.94 152.66 159.26 136.61 129.51 124.86 112.15 90.94 87.34 76.56 Payable days 57.86 42.82 37.91 30.30 26.74 26.74 27.25 21.28 15.09 11.03 Cash Conversion Cycle 49.96 146.80 169.72 152.65 152.44 152.57 135.32 107.37 106.14 99.25 Total Debt/Equity 0.13 0.68 0.90 0.85 0.80 0.77 0.70 0.63 0.72 0.74 Interest Cover 4.73 0.40 -0.17 0.23 0.41 1.09 1.06 3.35 3.55 2.85

Top Investors:

guttikonda vara lakshmi

rajasekhar guttikonda

Annual Reports:

News Update:

Venus Remedies gets CII’s Responsible Export Organisation Certification
13th Apr 2022, 18:00 PM

The company is poised to set industry standards which enhance the competitiveness of Indian exports
Read More
Venus Remedies wins WHO GDP certification for quality services across entire supply chain
9th Mar 2022, 12:59 PM

The company has consistently maintained impeccable standards in its distribution operations and processes through proven quality management systems
Read More

Venus Remedies Ltd.

Pharmaceuticals & Drugs

BSE: 526953 | NSE: VENUSREM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Venus Remedies Ltd.

Pharmaceuticals & Drugs

BSE: 526953 | NSE: VENUSREM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: